Drug Type Monoclonal antibody |
Synonyms Inclacumab (USAN/INN), DSM ACC2641, DSM-ACC-2641 + [11] |
Target |
Mechanism P-sel inhibitors(P-selectin inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationOrphan Drug (US), Rare Pediatric Disease (US) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10356 | Inclacumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Phase 3 | US | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | BR | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | CO | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | EG | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | FR | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | DE | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | GH | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | IT | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | KE | 04 Oct 2021 | |
Anemia, Sickle Cell | Phase 3 | LB | 04 Oct 2021 |
Phase 2 | 544 | jqmdnpgfhw(nhuihbyhzk) = sccdrrkifx rjunaemnrk (qrxpjygvcx ) | - | 16 Nov 2016 | |||
Phase 2 | 292 | fcslkjxrre(vyddmpxblq) = xeuhjgiruh cshtaaodzu (pgapfsphgu ) View more | Negative | 26 Jan 2016 | |||
Placebo | fcslkjxrre(vyddmpxblq) = luiujixlvg cshtaaodzu (pgapfsphgu ) View more | ||||||
Phase 2 | 544 | fbnvnjrgxh(jtdqhftqgv) = ygesamaibq qciaohlqmr (mchyatgvhy ) View more | Positive | 21 May 2013 | |||
Placebo | jozqhfvyix(jjmimqvstq) = jyihijtqqf kmsfsgyhjm (itkxzlzggf ) |